abstract |
An eRF3 capable of prionizing a heterologous eRF3 and an eRF3 capable of being prionized by a heterologous eRF3 are provided. Using these, screening for substances that inhibit abnormal PrP infection, detection of abnormal PrP, preparation of abnormal PrP, and screening of substances that restore abnormal PrP to normal PrP are performed. |